Details for Patent: 11,806,555

Which drugs does patent 11,806,555 protect, and when does it expire?

Patent 11,806,555 protects OLUMIANT and is included in one NDA.

This patent has thirty-five patent family members in twelve countries.

Drugs Protected by US Patent 11,806,555

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Eli Lilly And Co	OLUMIANT	baricitinib	TABLET;ORAL	207924-002	Oct 8, 2019		RX	Yes	No						TREATMENT OF ADULT PATIENTS WITH SEVERE ALOPECIA AREATA
Eli Lilly And Co	OLUMIANT	baricitinib	TABLET;ORAL	207924-001	May 31, 2018		RX	Yes	No						TREATMENT OF ADULT PATIENTS WITH SEVERE ALOPECIA AREATA
Eli Lilly And Co	OLUMIANT	baricitinib	TABLET;ORAL	207924-003	May 10, 2022		RX	Yes	Yes						TREATMENT OF ADULT PATIENTS WITH SEVERE ALOPECIA AREATA

International Family Members for US Patent 11,806,555

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
China	103370076
China	104334191
Denmark	2635299
Denmark	2830662
European Patent Office	2635299
European Patent Office	2830662
European Patent Office	3459565